Topical therapy drugs containing silver in acute adenoiditis sinusitis in children

The article  presents  the  results  of Russian authors’ research  aimed at studying the  clinical efficacy of topical  drugs containing silver in treating  acute  serous adenoiditis  and sinusitis in children. The authors  noted  the efficacy and safety of the drug (silver proteinate and polyvinyl-...

Full description

Bibliographic Details
Main Author: I. M. Kirichenko
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-03-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/5540
_version_ 1797842200473632768
author I. M. Kirichenko
author_facet I. M. Kirichenko
author_sort I. M. Kirichenko
collection DOAJ
description The article  presents  the  results  of Russian authors’ research  aimed at studying the  clinical efficacy of topical  drugs containing silver in treating  acute  serous adenoiditis  and sinusitis in children. The authors  noted  the efficacy and safety of the drug (silver proteinate and polyvinyl-N-pyrrolidone) in the complex treatment of inflammatory diseases  of the nose and paranasal sinuses in children. Clinical observation  was carried out – comparison  of two groups of 30 patients aged from 5 to 14 years, average  age 6 years 3 months, the groups included: 17 boys (56.7%) and 13 girls (43.3%), all children had adenoid  vegetations of the 1st-2nd degree. To assess the clinical efficacy of the drug, a control group of children with similar pathology was recruited, comparable  in age and sex (14 boys and 16 girls). The main group received the drug Sialor and irrigation therapy. The control group received local antibacterial drugs and decongestants according to age. At the beginning of treatment normal values of mucociliary transport  were not observed  in any patient  (0%) of the main and control groups. Disorder of the 1st degree  mucociliary transport  function was determined in 6 children (20%) of the main group and 7 children (23.3%) of the control group, 2nd degree  – in 21 children (70%) of the main group and 19 children (63.3%) of the control group, 3rd degree – in 3 (10%) patients of the main group and 4 children (13.4%) of the control group. In 7 days from the beginning of treatment normal values of MCT were observed in 28 patients (93.3%) of the main group and 9 patients (30%) of the control group, the disorder of MCT function of the 1st degree  had 3 patients (9%) of the main and control groups, the 2nd degree  was not in the main group and was revealed  in 18 patients (60%) of the control group, no disorder of MCT function of the 3rd degree  was revealed  (neither in the main nor control groups).The average  time of MCT was: before treatment – 49 minutes  (main group) and 47 minutes  (control group), the 3rd day of treatment – 28 minutes (main group) and 36 minutes (control group). On the 7th day of the drug intake – 14 minutes (main group) and 21 minutes  (control group). Thus, normalization  of MCT time was noted only in patients of the main group. On the 7th day of treatment with Sialor in the main group of children under examination,  nasal mucosa edema, nasal excretion  and adenoid  tissue size decreased, mucociliary transport parameters normalized, nasal breathing improved.Sialor has a pronounced  anti-inflammatory and anti-edema effect, is well tolerated by patients and can be recommended for inclusion in standard  treatment protocols of patients with diseases  of the nasal cavity, paranasal sinuses.
first_indexed 2024-04-09T16:43:57Z
format Article
id doaj.art-d703b51e53ff4d2d89058c15c2325955
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:43:57Z
publishDate 2020-03-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-d703b51e53ff4d2d89058c15c23259552023-04-23T06:56:33ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902020-03-010110110510.21518/2079-701X-2020-1-101-1055040Topical therapy drugs containing silver in acute adenoiditis sinusitis in childrenI. M. Kirichenko0Peoples’ Friendship University of RussiaThe article  presents  the  results  of Russian authors’ research  aimed at studying the  clinical efficacy of topical  drugs containing silver in treating  acute  serous adenoiditis  and sinusitis in children. The authors  noted  the efficacy and safety of the drug (silver proteinate and polyvinyl-N-pyrrolidone) in the complex treatment of inflammatory diseases  of the nose and paranasal sinuses in children. Clinical observation  was carried out – comparison  of two groups of 30 patients aged from 5 to 14 years, average  age 6 years 3 months, the groups included: 17 boys (56.7%) and 13 girls (43.3%), all children had adenoid  vegetations of the 1st-2nd degree. To assess the clinical efficacy of the drug, a control group of children with similar pathology was recruited, comparable  in age and sex (14 boys and 16 girls). The main group received the drug Sialor and irrigation therapy. The control group received local antibacterial drugs and decongestants according to age. At the beginning of treatment normal values of mucociliary transport  were not observed  in any patient  (0%) of the main and control groups. Disorder of the 1st degree  mucociliary transport  function was determined in 6 children (20%) of the main group and 7 children (23.3%) of the control group, 2nd degree  – in 21 children (70%) of the main group and 19 children (63.3%) of the control group, 3rd degree – in 3 (10%) patients of the main group and 4 children (13.4%) of the control group. In 7 days from the beginning of treatment normal values of MCT were observed in 28 patients (93.3%) of the main group and 9 patients (30%) of the control group, the disorder of MCT function of the 1st degree  had 3 patients (9%) of the main and control groups, the 2nd degree  was not in the main group and was revealed  in 18 patients (60%) of the control group, no disorder of MCT function of the 3rd degree  was revealed  (neither in the main nor control groups).The average  time of MCT was: before treatment – 49 minutes  (main group) and 47 minutes  (control group), the 3rd day of treatment – 28 minutes (main group) and 36 minutes (control group). On the 7th day of the drug intake – 14 minutes (main group) and 21 minutes  (control group). Thus, normalization  of MCT time was noted only in patients of the main group. On the 7th day of treatment with Sialor in the main group of children under examination,  nasal mucosa edema, nasal excretion  and adenoid  tissue size decreased, mucociliary transport parameters normalized, nasal breathing improved.Sialor has a pronounced  anti-inflammatory and anti-edema effect, is well tolerated by patients and can be recommended for inclusion in standard  treatment protocols of patients with diseases  of the nasal cavity, paranasal sinuses.https://www.med-sovet.pro/jour/article/view/5540acute adenoiditis and sinusitis in childrentopical silver preparationseffectiveness
spellingShingle I. M. Kirichenko
Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
Медицинский совет
acute adenoiditis and sinusitis in children
topical silver preparations
effectiveness
title Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
title_full Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
title_fullStr Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
title_full_unstemmed Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
title_short Topical therapy drugs containing silver in acute adenoiditis sinusitis in children
title_sort topical therapy drugs containing silver in acute adenoiditis sinusitis in children
topic acute adenoiditis and sinusitis in children
topical silver preparations
effectiveness
url https://www.med-sovet.pro/jour/article/view/5540
work_keys_str_mv AT imkirichenko topicaltherapydrugscontainingsilverinacuteadenoiditissinusitisinchildren